CG Oncology, Inc. Common stock

Net selling: insiders sold $148K and bought $0 of CGON stock on the open market in the 90 days to Nov 1, 2026, according to SEC Form 4 filings. $148K of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Post, Leonard E (Director), who sold $148K. The latest filing was on Sep 17, 2026.

None. No member of Congress disclosed a CGON trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.

This summary uses filings available on Nov 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.